Dupixent (dupilumab)
pCPA File Number:
22496
Negotiation Status:
Under consideration for negotiation
Indication(s):
Atopic dermatitis, pediatrics
Sponsor/Manufacturer:
Sanofi Genzyme
CADTH Project Number:
SR0774-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable